225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy - an in vitro and in vivo evaluation

被引：0
|
作者：
Rodak, Magdalena [1 ]
Dekempeneer, Yana [2 ]
Wojewodzka, Maria [1 ]
Lahoutte, Tony [3 ]
Bruchertseifer, Frank [4 ]
Morgenstern, Alfred [4 ]
D'Huyvetter, Matthias [3 ]
Pruszynski, Marek [1 ]
机构：
[1] Inst Nucl Chem & Technol, Warsaw, Poland
[2] Nucl Res Ctr, Brussels, Belgium
[3] Vrije Univ Brussel, Brussels, Belgium
[4] Inst Transuranium Elements, Karlsruhe, Germany
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2021年 / 96-97卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
SSP-30
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 35 条
  • [1] Evaluation of an Anti-HER2 Nanobody Labeled with 225AC for Targeted α-Particle Therapy of Cancer
    Pruszynski, Marek
    D'Huyvetter, Matthias
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Lahoutte, Tony
    MOLECULAR PHARMACEUTICS, 2018, 15 (04) : 1457 - 1466
  • [2] In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac
    Kateřina Ondrák Fialová
    Lukáš Ondrák
    Martin Vlk
    Ján Kozempel
    Kateřina Nováková
    Zbyněk Nový
    Katarína Hajduová
    Marián Hajdúch
    Miloš Petřík
    Marek Pruszynski
    Frank Bruchertseifer
    Alfred Morgenstern
    EJNMMI Radiopharmacy and Chemistry, 10 (1)
  • [3] Anti HER2 Nanobody Labeled with 225Ac as a Potential Radiopharmaceutical for TRT
    Pruszynski, M.
    Cedrowska, E.
    Radchenko, V.
    John, K. D.
    Bruchertseifer, F.
    Morgenstern, A.
    D'Huyvetter, M.
    Lahoutte, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S177 - S177
  • [4] Anti-HER2 Single Domain Antibody 2Rs15d Labeled with 18F Using a Residualizing Label: Preliminary Evaluation
    Vaidyanathan, G. V.
    Zhou, Z.
    McDougald, D.
    Lahoutte, T.
    Zalutsky, M. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S179 - S179
  • [5] Efficacy and safety of novel [225Ac]Ac-labeled anti-HER2 antibody drug radioconjugates against HER2 positive breast cancer xenografts
    Ketchemen, J. Pougoue
    Monzar, A.
    Njotu, F. Ngoh
    Babeker, H.
    Tikum, A.
    Nwangele, E.
    Henning, N.
    Hassani, N.
    Doroudi, A.
    Fonge, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S42 - S42
  • [6] Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma
    Cortez, Angel
    Josefsson, Anders
    McCarty, Greg
    Shtekler, Abigail E.
    Rao, Akhila
    Austin, Zachery
    Nedrow, Jessie R.
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 88-89 : 62 - 72
  • [7] In vitro and in vivo evaluation of bismuth-213 labeled anti-HER2 nanobodies
    Dekempeneer, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S57 - S58
  • [8] Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody-Drug Radioconjugate
    Pougoue Ketchemen, Jessica
    Njotu, Fabrice Ngoh
    Babeker, Hanan
    Monzer, Alissar
    Nwangele, Emmanuel
    Tikum, Anjong Florence
    Henning, Nikita
    Hassani, Nava
    Frye, Sarah
    Perron, Randy
    Byrne, Chris
    Didychuk, Candice
    Qi, Qi
    Bannister, Laura
    Doroudi, Alireza
    Fonge, Humphrey
    CLINICAL CANCER RESEARCH, 2025, 31 (04) : 685 - 696
  • [9] Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy
    Cedrowska, Edyta
    Pruszynski, Marek
    Majkowska-Pilip, Agnieszka
    Meczynska-Wielgosz, Sylwia
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Bilewicz, Aleksander
    JOURNAL OF NANOPARTICLE RESEARCH, 2018, 20 (03)
  • [10] Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy
    Edyta Cędrowska
    Marek Pruszynski
    Agnieszka Majkowska-Pilip
    Sylwia Męczyńska-Wielgosz
    Frank Bruchertseifer
    Alfred Morgenstern
    Aleksander Bilewicz
    Journal of Nanoparticle Research, 2018, 20
1234